VivoSim Labs, Inc. Payments for Restructuring
VivoSim Labs, Inc. (VIVS) reported Payments for Restructuring of $2.57 million for the 9-month period ending 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2020-02-10
- VivoSim Labs, Inc. payments for restructuring for the quarter ending 2019-12-31 was $920.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month |
|---|---|---|---|
| 2019-12-31 | $920.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $2.57M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $1.65M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |